Association between systemic inflammatory response index and left ventricular remodeling and systolic dysfunction in atrial fibrillation patients

被引:3
作者
Chi, Runze [1 ]
Shan, Xiaoli [1 ]
Guan, ChunPing [1 ]
Yang, Hao [2 ]
Wang, Xiangkun [1 ]
Li, Bingong [3 ]
Zhang, Qing [3 ]
机构
[1] Qingdao Univ, Qingdao Municipal Hosp, Affiliated Qingdao Municipal Hosp, Qingdao 266011, Shandong, Peoples R China
[2] Weifang Med Univ, Weifang 261000, Shandong, Peoples R China
[3] Univ Hlth & Rehabil Sci, Qingdao Hosp, Qingdao Municipal Hosp, Dept Cardiol, Qingdao 266011, Shandong, Peoples R China
关键词
Atrial fibrillation; Left ventricular remodeling; Left ventricular systolic dysfunction; Systemic inflammatory response index; HEART-FAILURE; OUTCOMES;
D O I
10.1186/s12872-023-03403-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundCardiac remodeling and dysfunction can be caused by atrial fibrillation (AF). The aim of this research is to investigate the relationship between the systemic inflammatory response index (SIRI) and left ventricular (LV) remodeling and systolic function in individuals with AF.Methods416 patients with AF who were admitted to the Second Department of Cardiology in the East Ward of the Qingdao Municipal Hospital between January 2020 and May 2022 were included in the present retrospective research. The relationship between SIRI and various cardiac parameters was analyzed. The patients' left atrial (LA) enlargement and left ventricular (LV) hypertrophy and systolic dysfunction were evaluated. SIRI was calculated by the formula: neutrophil x monocyte/lymphocyte.ResultsSIRI significantly correlated with LV end-diastolic diameter (LVDd), LV posterior wall thickness at end-diastole (LVPWTd), interventricular septal thickness at end-diastole (IVSTd), LV mass index (LVMI), LV ejection fraction (LVEF), LA diameter (LAD), C-reactive protein (CRP), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with AF. In multivariate linear regression analyses, SIRI was discovered to be significantly related to LVMI (ln-transformed) (p = 0.025), LVEF (ln-transformed) (p = 0.005), and LAD (ln-transformed) (p = 0.007). In multivariate logistic regression, the highest quartile of SIRI (SIRI > 1.62) was significantly associated with LV hypertrophy (p = 0.026), impaired LV systolic function (p = 0.002), and LA enlargement (p = 0.025).ConclusionsSIRI was significantly associated with LV remodeling and systolic function impairment in patients with AF. SIRI may serve as a reliable and convenient inflammatory biomarker for detecting impaired cardiac structure and systolic function in patients with AF.
引用
收藏
页数:11
相关论文
共 52 条
  • [1] ALVAREZ C, 1986, CLIN CHEM, V32, P142
  • [2] Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction
    Ammirati, Enrico
    Veronese, Giacomo
    Brambatti, Michela
    Merlo, Marco
    Cipriani, Manlio
    Potena, Luciano
    Sormani, Paola
    Aoki, Tatsuo
    Sugimura, Koichiro
    Sawamura, Akinori
    Okumura, Takahiro
    Pinney, Sean
    Hong, Kimberly
    Shah, Palak
    Braun, Oscar
    Van de Heyning, Caroline M.
    Montero, Santiago
    Petrella, Duccio
    Huang, Florent
    Schmidt, Matthieu
    Raineri, Claudia
    Lala, Anuradha
    Varrenti, Marisa
    Foa, Alberto
    Leone, Ornella
    Gentile, Piero
    Artico, Jessica
    Agostini, Valentina
    Patel, Rajiv
    Garascia, Andrea
    Van Craenenbroeck, Emeline M.
    Hirose, Kaoru
    Isotani, Akihiro
    Murohara, Toyoaki
    Arita, Yoh
    Sionis, Alessandro
    Fabris, Enrico
    Hashem, Sherin
    Garcia-Hernando, Victor
    Oliva, Fabrizio
    Greenberg, Barry
    Shimokawa, Hiroaki
    Sinagra, Gianfranco
    Adler, Eric D.
    Frigerio, Maria
    Camici, Paolo G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) : 299 - 311
  • [3] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [4] Predictors and outcomes of heart failure with mid-range ejection fraction
    Bhambhani, Vijeta
    Kizer, Jorge R.
    Lima, Joao A. C.
    van der Harst, Pim
    Bahrami, Hossein
    Nayor, Matthew
    de Filippi, Christopher R.
    Enserro, Danielle
    Blaha, Michael J.
    Cushman, Mary
    Wang, Thomas J.
    Gansevoort, Ron T.
    Fox, Caroline S.
    Gaggin, Hanna K.
    Kop, Willem J.
    Liu, Kiang
    Vasan, Ramachandran S.
    Psaty, Bruce M.
    Lee, Douglas S.
    Brouwers, Frank P.
    Hillege, Hans L.
    Bartz, Traci M.
    Benjamin, Emelia J.
    Chan, Cheeling
    Allison, Matthew
    Gardin, Julius M.
    Januzzi, James L., Jr.
    Levy, Daniel
    Herrington, David M.
    van Gilst, Wiek H.
    Bertoni, Alain G.
    Larson, Martin G.
    de Boer, Rudolf A.
    Gottdiener, John S.
    Shah, Sanjiv J.
    Ho, Jennifer E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (04) : 651 - 659
  • [5] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
    Bhatt, Deepak L.
    Szarek, Michael
    Steg, P. Gabriel
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Voors, Adriaan A.
    Metra, Marco
    Lund, Lars H.
    Komajda, Michel
    Testani, Jeffrey M.
    Wilcox, Christopher S.
    Ponikowski, Piotr
    Lopes, Renato D.
    Verma, Subodh
    Lapuerta, Pablo
    Pitt, Bertram
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 117 - 128
  • [6] Atrial fibrillation
    Brundel, Bianca J. J. M.
    Ai, Xun
    Hills, Mellanie True
    Kuipers, Myrthe F.
    Lip, Gregory Y. H.
    de Groot, Natasja M. S.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2022, 8 (01)
  • [7] Estrogen is a modulator of vascular inflammation
    Chakrabarti, Subhadeep
    Lekontseva, Olga
    Davidge, Sandra T.
    [J]. IUBMB LIFE, 2008, 60 (06) : 376 - 382
  • [8] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675
  • [9] Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
    Cohn, JN
    Ferrari, R
    Sharpe, N
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 569 - 582
  • [10] European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions
    Crespo-Leiro, Maria G.
    Anker, Stefan D.
    Maggioni, Aldo P.
    Coats, Andrew J.
    Filippatos, Gerasimos
    Ruschitzka, Frank
    Ferrari, Roberto
    Piepoli, Massimo Francesco
    Delgado Jimenez, Juan F.
    Metra, Marco
    Fonseca, Candida
    Hradec, Jaromir
    Amir, Offer
    Logeart, Damien
    Dahlstroem, Ulf
    Merkely, Bela
    Drozdz, Jaroslaw
    Goncalvesova, Eva
    Hassanein, Mahmoud
    Chioncel, Ovidiu
    Lainscak, Mitja
    Seferovic, Petar M.
    Tousoulis, Dimitris
    Kavoliuniene, Ausra
    Fruhwald, Friedrich
    Fazlibegovic, Emir
    Temizhan, Ahmet
    Gatzov, Plamen
    Erglis, Andrejs
    Laroche, Cecile
    Mebazaa, Alexandre
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (06) : 613 - 625